Pharmaceutical company Moderna is also developing a bird flu vaccine for humans and has received about $766 million from the U.S. government for its advancement. The company said last month it was ...
Previous bird flu outbreaks and decades-old public health infrastructure have led industry to protect the hens used for ...
The Trump administration is looking to move away from depopulating entire flocks infected by Bird Flu. The focus will instead ...
Millie, a modern maternity clinic, secured $12 million in Series A funding led by existing investors RH Capital, TMV, ...
To that end, HHS has granted Moderna $590 million to help accelerate the development of a bird flu vaccine. The agency announced its backing of the Massachusetts-based pharmaceutical firm about 72 ...
In its fourth-quarter earnings report, Moderna’s revenue was down substantially from 2023. Separately, media reports reveal ...
BofA analyst Tim Anderson lowered the firm’s price target on Moderna (MRNA) to $32 from $34 and keeps an Underperform rating on the shares.
It marks another quarter of growing pains for the company, which is racing to launch new products and recover from the ...
Moderna is revamping its digital team, eliminating 10% of roles under two digital departments, affecting about 50 employees, ...